Docket #: S11-232
Treatment of Ocular Diseases Using Device Which Modulates Pathological Neural Pathways
Stanford researchers have developed a device and method aimed at intranasal neurostimulation for treating ocular diseases. As a non-surgical and non-implantable device, this system can be used at home by patients as needed to treat a diseases such as dry eye, eye twitch, allergies, occular migrane etc. Many of these diseases are currently ineffectively managed using pharmaceuticals and this system is able to provide improved patient outcomes with fewer overall side effects.
Stage of development
FDA cleared
Applications
- Treatment of Various Ocular Conditions:
- Dry eye, Eye twitch, Glaucoma
- Allergy, Ocular Migraine, etc
- Implantable Medical Devices
Advantages
- Increased efficacy expected
Patents
- Published Application: WO2012068247
- Published Application: 20120130398
- Published Application: 20150088156
- Published Application: 20150335900
- Published Application: 20180064940
- Published Application: 20180064941
- Published Application: 20180154161
- Published Application: 20190290922
- Published Application: 20210008379
- Published Application: 20230405339
- Issued: 8,918,181 (USA)
- Issued: 9,821,159 (USA)
- Issued: 10,835,748 (USA)
- Issued: 10,143,846 (USA)
- Issued: 10,722,718 (USA)
- Issued: 11,771,908 (USA)
Similar Technologies
-
New Light Control Mechanism (NpHR) That Inhibits Neural Activity S06-398New Light Control Mechanism (NpHR) That Inhibits Neural Activity
-
Structure-guided transformation of channelrhodopsin into a light-activated chloride channel S14-125Structure-guided transformation of channelrhodopsin into a light-activated chloride channel
-
bReaCh-ES: An optogenetic tool for stimulating neurons with red light S15-285bReaCh-ES: An optogenetic tool for stimulating neurons with red light